BridgeBio Pharma (BBIO) PT Raised to $40 at Raymond James
Tweet Send to a Friend
Raymond James analyst Dane Leone raised the price target on BridgeBio Pharma (NASDAQ: BBIO) to $40.00 (from $36.00) while maintaining ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
